Family Interventions for Adolescent Substance Use
(PCYF Trial)
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to compare a standard adolescent-only approach to substance use screening, brief intervention, and referral to treatment to a in primary care settings. Primary outcomes (AOD use, co-occurring behavior problems, parent-youth communication about AOD use) and secondary outcomes (adolescent quality of life, therapy attendance) are assessed at screen/initial and 3, 6, 9, and 12 months follow-up.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Family Interventions for Adolescent Substance Use?
Research shows that family-based treatments for adolescent substance use, like the ones in this trial, can improve treatment outcomes by involving family members in the therapy process. These approaches have been effective in enhancing engagement, retention, and overall family functioning, which are crucial for successful treatment.12345
Is family-based intervention for adolescent substance use generally safe?
Family-based interventions, like Brief Strategic Family Therapy and other similar methods, have been studied in various settings and are generally considered safe for adolescents and their families. These therapies focus on improving family dynamics and addressing substance use without significant safety concerns reported in the research.678910
How is the Family Interventions for Adolescent Substance Use treatment different from other treatments?
This treatment is unique because it involves the family in the therapy process, focusing on improving family communication and support, which can help address the root causes of substance use in adolescents. Unlike many other treatments that focus solely on the individual, this approach includes both the adolescent and their family, aiming to strengthen family dynamics and resilience.610111213
Research Team
Aaron Hogue, PhD
Principal Investigator
Partnership to End Addiction
Eligibility Criteria
This trial is for youths aged 12-17 with substance use disorders, who come to primary care appointments with a caregiver. Both must be fluent in English or Spanish and able to use a tablet for consent procedures.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive either a standard adolescent-only approach or a family-based approach to substance use screening, brief intervention, and referral to treatment
Follow-up
Participants are monitored for primary and secondary outcomes at 3, 6, 9, and 12 months
Treatment Details
Interventions
- Family Brief Negotiated Interview (BNI)
- Family Facilitated Conversation (FC) & Referral to Treatment (RT)
- Family Psychoeducation
Family Brief Negotiated Interview (BNI) is already approved in United States for the following indications:
- Substance use screening and intervention in adolescents
Find a Clinic Near You
Who Is Running the Clinical Trial?
The National Center on Addiction and Substance Abuse at Columbia University
Lead Sponsor
Columbia University
Collaborator
Abt Associates
Industry Sponsor
UConn Health
Collaborator
Northwestern University Feinberg School of Medicine
Collaborator
Massachusetts General Hospital
Collaborator
Boston Children's Hospital
Collaborator
Patient-Centered Outcomes Research Institute
Collaborator
Boston Medical Center
Collaborator